We are live on ! Find out more
NARI

Inari Medical, Inc. Common Stock

Delisted

NARI was delisted on the 18th of February, 2025.

231 hedge funds and large institutions have $2.65B invested in Inari Medical, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 89 increasing their positions, 82 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

9% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 82

8% less funds holding

Funds holding: 252231 (-21)

18% less capital invested

Capital invested by funds: $3.24B → $2.65B (-$584M)

34% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 53

51% less call options, than puts

Call options by funds: $4.86M | Put options by funds: $9.88M

Holders
231
Holders Change
-21
Holders Change %
-8.33%
% of All Funds
3.33%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
35
Increased
89
Reduced
82
Closed
53
Calls
$4.86M
Puts
$9.88M
Net Calls
-$5.02M
Net Calls Change
+$17.5M
Name Holding Trade Value Shares
Change
Change in
Stake
FAM
26
Fred Alger Management
New York
$23M +$1.32M +24,718 +5%
Barclays
27
Barclays
United Kingdom
$20.4M +$16.4M +306,994 +260%
SPC
28
Slate Path Capital
New York
$20.1M
Bank of New York Mellon
29
Bank of New York Mellon
New York
$19.9M -$3.75M -70,209 -14%
Charles Schwab
30
Charles Schwab
California
$19.8M +$330K +6,186 +2%
PE
31
Point72 Europe
United Kingdom
$19.5M +$4.01M +75,033 +23%
Bank of America
32
Bank of America
North Carolina
$19.4M +$11.9M +221,874 +121%
T. Rowe Price Associates
33
T. Rowe Price Associates
Maryland
$17.9M +$107K +2,003 +0.5%
Balyasny Asset Management
34
Balyasny Asset Management
Illinois
$17.7M +$9.83M +184,051 +100%
Jennison Associates
35
Jennison Associates
New York
$16.5M -$5.35M -100,070 -23%
Principal Financial Group
36
Principal Financial Group
Iowa
$14.8M -$13.8M -258,484 -46%
SCM
37
Soleus Capital Management
Connecticut
$13.3M +$14.8M +277,000 New
SSA
38
Schonfeld Strategic Advisors
New York
$12.4M +$13.9M +259,424 New
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$12.4M +$15.9K +298 +0.1%
ClearBridge Investments
40
ClearBridge Investments
New York
$12M +$3.89M +72,802 +41%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$11.9M -$3.33M -62,426 -20%
Goldman Sachs
42
Goldman Sachs
New York
$11.6M +$3.2M +59,969 +33%
AC
43
Armistice Capital
New York
$10.7M +$9.42M +176,429 +381%
Squarepoint
44
Squarepoint
New York
$10.5M +$2.18M +40,884 +23%
FLAM
45
First Light Asset Management
Minnesota
$10.3M +$11.4M +213,940 New
Ameriprise
46
Ameriprise
Minnesota
$9.78M +$2.94M +54,958 +37%
IHAM
47
Integral Health Asset Management
New York
$9.6M +$5.34M +100,000 +100%
Amundi
48
Amundi
France
$9.16M -$465K -8,714 -4%
ECM
49
ExodusPoint Capital Management
New York
$8.44M +$1.76M +32,930 +23%
AAA
50
Affinity Asset Advisors
New York
$8.4M +$8.28M +155,000 +775%

NARI Hedge Fund Activity: Q1 2024 in Review

231 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q1 2024, worth a combined $2.65B — down 18% from $3.24B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of NARI and 35 opened new positions — a net loss of 18 holders — while 82 trimmed existing stakes and 89 added.

The largest buyer was BlackRock, adding an estimated $95.4M. The largest seller was Wellington Management Group, cutting an estimated $177M.

  • 231 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q1 2024, down from 252 in Q4 2023.
  • Funds reported $2.65B of Inari Medical, Inc. Common Stock stock for Q1 2024, down 18% quarter-over-quarter.
  • 35 funds opened new Inari Medical, Inc. Common Stock positions in Q1 2024 and 53 closed out, a net change of -18 holders.
  • The largest Inari Medical, Inc. Common Stock buyer in Q1 2024 was BlackRock, an estimated $95.4M added.
  • The largest Inari Medical, Inc. Common Stock seller in Q1 2024 was Wellington Management Group, an estimated $177M sold.

Based on aggregated 13F filings for Q1 2024.